Press Resease

Embolotherapy Market - Global Industry Analysis

Embolotherapy Market by Disease (Aneurysm, Oncology, Peripheral Vascular), Product (Guidewires, Embolic Agents (Detachable Coils, Microspheres, Pushable Coils)), Procedure, End User (Clinics, Hospitals, Academia, ASC) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Published Date: 04-Sep-2019 Category: Medical Device Report Format : PDF Pages: 130 Report Code: ZMR-4673 Status : Published

Global embolotherapy market is expected to surpass USD 5.3 billion by 2025 from USD 3.5 billion in 2019 with a CAGR of 8.5%

Description

Global Embolotherapy Market: An Overview

The global embolotherapy market is a fragmented, and competitive landscape. The rising demand for embolotherapy to treat cases of trauma, tumor, and for male infertility, and impotence promises major growth for the market in near future.

Embolotherapy today plays a more important role in medicine than ever before. The treatment, endovascular in nature promises to control bleeding, reduction in tumors, close arteriovenous, among others. The technique is increasingly moving towards minimal-invasive procedures which will likely present major benefits to the rising elderly, and chronic-disease ridden patient population. The success of the treatment relies on a wide variety of gel foams, angiographic catheters, coils, balloons, and skilled surgeons. The therapy can be permanent or temporary in nature, and varies widely depending on the application.

According to ZMR’s latest study, the embolotherapy market will register significant growth during 2019-2025, growing at a robust 8.5% CAGR. The rising investments, grants by public and private institutions, and rising cases of chronic illnesses like liver cancer will spell major growth for the market during the forecast period. According to the ZMR study, the market reached a valuation of $3.5 bn in 2019, and will likely cross $5.3 bn by 2025 end.

Global Embolotherapy Market: Key Trends

According to the latest reports by Center for Disease Control and Prevention (CDC), each year 33,000 people in the US are diagnosed with liver cancer. Among these, over 27,000 patients die from the illness. Additionally, the percentage of people receiving liver cancer has steadily been on the rise in the last decade. Moreover, the percentage of people who survive beyond five years remains extremely low with percentage hovering between 4 to 26.

On the other hand, strokes also remains a key opportunity for improving the lives of patients for players in the global embolotherapy market. Strokes remains the fifth-leading cause of deaths in the United States, with 7,95,000 cases incidences reported annually.

Additionally, diseases like uterine fibroid are also witnessing a growing rate of diagnosis, thanks to rising awareness of the disease, and increasingly effective treatment procedure. The disease remains a common occurrences among women. Most women develop the condition between 20-80 years of age, and 35% of women experience the condition before they reach menopause.

The rising occurrences of several chronic diseases including cancer, strokes, and their growing adverse effects on the elderly population will create significant opportunities for growth in the global embolotherapy market in near future.

Global Embolotherapy Market: Segmentation

The global embolotherapy market report is segmented on the basis of disease, products, procedure, end-users, and region. Among type of disease, oncology, aneurysm, peripheral vascular conditions will be studied. The product segement of the report will cover guidewires, detachable coils, embolic agents, pushable coils, and microspheres. Moreover, the data from clinics, hospitals, academia, and ASC will also be presented in the end-user segment.

Global Embolotherapy Market: Regional Analysis

The global embolotherapy market will cover all key regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these, the rising investment in healthcare in the US, will likely create major opportunities for growth in the North America region. Recent legislations in the US has extended programs like Medicare for all elderly patients above 65 years of age. Among other regions, the Asia Pacific region will likely witness highest CAGR-driven growth, thanks to rising disposable income, and growing access to healthcare.

Global Embolotherapy Market: Competitive Analysis

The global embolotherapy market remains an innovative landscape, wherein large fragmentation in the market continues to drive robust innovation. The growing technological advancements, and increasing demand for minimal-invasive surgeries will also fuel further growth for innovation during the forecast period. Some key players in the global embolotherapy market are Merit Medical Systems, Boston Scientific Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd.

 The global embolotherapy market is segmented as follows:

By Product

  • Embolic agents
  • Microspheres
  • Embolic coils
    • Detachable Coils
    • Pushable Coils
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Detachable Balloons
  • Support Devices
  • Microcatheters
  • Guidewires

By Disease Indication

  • Cancer
  • Liver Cancer
  • Kidney Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Neurological Diseases
  • Cerebral Aneurysm
  • Cerebral Arteriovenous Malformations and Fistulas
  • Gastrointestinal Disorders
  • Urological and Nephrological Disorders

By Procedure

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content


List of Figures

1. Market research process
2. Market research methodology
3. Global embolotherapy market, 2019 - 2025 (USD Million)
4. Porter’s five forces analysis: embolotherapy market
5. Global embolotherapy market attractiveness, by product
6. Global embolotherapy market attractiveness, by procedure
7. Global embolotherapy market attractiveness, by disease indication
8. Global embolotherapy market attractiveness, by end user
9. Global embolotherapy market revenue share, by product, 2019 and 2025
10. Global embolotherapy market by embolic agents, 2019 - 2025 (USD Million)
11. Global embolotherapy market by microspheres, 2019 - 2025 (USD Million)
12. Global embolotherapy market by embolic coils, 2019 - 2025 (USD Million)
13. Global embolotherapy market by liquid embolic agents, 2019 - 2025 (USD Million)
14. Global embolotherapy market by embolic plug systems, 2019 - 2025 (USD Million)
15. Global embolotherapy market by detachable balloons, 2019 - 2025 (USD Million)
16. Global embolotherapy market by support devices, 2019 - 2025 (USD Million)
17. Global embolotherapy market by microcatheters, 2019 - 2025 (USD Million)
18. Global embolotherapy market by others, 2019 - 2025 (USD Million)
19. Global embolotherapy market revenue share, by procedure, 2019 and 2025
20. Global embolotherapy market by transcatheter arterial embolization, 2019 - 2025 (USD Million)
21. Global embolotherapy market by transcatheter arterial radio-embolization/ selective internal radiation therapy, 2019 - 2025 (USD Million)
22. Global embolotherapy market by transarterial chemoembolization, 2019 - 2025 (USD Million)
23. Global embolotherapy market revenue share, by disease indication, 2019 and 2025
24. Global embolotherapy market by cancer, 2019 - 2025 (USD Million)
25. Global embolotherapy market by peripheral vascular diseases, 2019 - 2025 (USD Million)
26. Global embolotherapy market by neurological diseases, 2019 - 2025 (USD Million)
27. Global embolotherapy market by cerebral aneurysm, 2019 - 2025 (USD Million)
28. Global embolotherapy market by cerebral arteriovenous malformations and fistulas, 2019 - 2025 (USD Million)
29. Global embolotherapy market by gastrointestinal disorders, 2019 - 2025 (USD Million)
30. Global embolotherapy market by urological and nephrological disorders, 2019 - 2025 (USD Million)
31. Global embolotherapy market by others, 2019 - 2025 (USD Million)
32. Global embolotherapy market revenue share, by end user, 2019 and 2025
33. Global embolotherapy market by hospitals and clinics, 2019 - 2025 (USD Million)
34. Global embolotherapy market by ambulatory surgical centers, 2019 - 2025 (USD Million)
35. Global embolotherapy market by others, 2019 - 2025 (USD Million)
36. Global embolotherapy market revenue share, by region, 2019 & 2025
37. North America embolotherapy market, 2019 - 2025 (USD Million)
38. Europe embolotherapy market, 2019 - 2025 (USD Million)
39. Asia Pacific embolotherapy market, 2019 – 2025 (USD Million)
40. Latin America embolotherapy market, 2019 - 2025 (USD Million)
41. Middle East & Africa embolotherapy market, 2019 – 2025 (USD Million)


List of Tables

1. Global embolotherapy market: snapshot
2. Drivers for embolotherapy market: impact analysis
3. Restraints for embolotherapy market: impact analysis
4. North America embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
5. North America embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
6. North America embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
7. North America embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
8. The U.S. embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
9. The U.S. embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
10. The U.S. embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
11. The U.S. embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
12. Rest of North America embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
13. Rest of North America embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
14. Rest of North America embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
15. Rest of North America embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
16. Europe embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
17. Europe embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
18. Europe embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
19. Europe embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
20. U.K. embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
21. U.K. embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
22. U.K. embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
23. U.K. embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
24. France embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
25. France embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
26. France embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
27. France embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
28. Germany embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
29. Germany embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
30. Germany embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
31. Germany embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
32. Rest of Europe embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
33. Rest of Europe embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
34. Rest of Europe embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
35. Rest of Europe embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
36. Asia Pacific embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
37. Asia Pacific embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
38. Asia Pacific embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
39. Asia Pacific embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
40. China embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
41. China embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
42. China embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
43. China embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
44. Japan embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
45. Japan embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
46. Japan embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
47. Japan embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
48. India embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
49. India embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
50. India embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
51. India embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
52. Rest of Asia Pacific embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
53. Rest of Asia Pacific embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
54. Rest of Asia Pacific embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
55. Rest of Asia Pacific embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
56. Latin America embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
57. Latin America embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
58. Latin America embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
59. Latin America embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
60. Brazil embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
61. Brazil embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
62. Brazil embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
63. Brazil embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
64. Rest of Latin America embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
65. Rest of Latin America embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
66. Rest of Latin America embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
67. Rest of Latin America embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)
68. Middle  East & Africa embolotherapy market revenue, by product, 2019 – 2025 (USD Million)
69. Middle East & Africa embolotherapy market revenue, by procedure, 2019 – 2025 (USD Million)
70. Middle  East & Africa embolotherapy market revenue, by disease indication, 2019 – 2025 (USD Million)
71. Middle East and Africa embolotherapy market revenue, by end user, 2019 – 2025 (USD Million)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global embolotherapy market was valued at USD$3.5 bn in 2019.

The global embolotherapy market will likely reach $5.3 bn by 2025.

The global embolotherapy market will rise at a promising 8.5% CAGR during 2019-2025 period.

North America will likely register highest total revenues during the forecast period, while Asia Pacific region will grow at the fastest CAGR.

Some main players in the global embolotherapy market include Merit Medical Systems, Boston Scientific Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed